Pharmacological Treatment for Hepatopulmonary Syndrome

Aim. Hepatopulmonary syndrome is a pulmonary dysfunction in the context of liver cirrhosis characterized by arterial deoxygenation. Affected patients have increased morbidity and mortality, and many of them expire before undergoing liver transplantation. Therefore, finding medical therapy as a bridg...

Descripción completa

Detalles Bibliográficos
Autores principales: Eshraghian, Ahad, Kamyab, Amir A'lam, Yoon, Seung Kew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786536/
https://www.ncbi.nlm.nih.gov/pubmed/24102057
http://dx.doi.org/10.1155/2013/670139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786536/
https://www.ncbi.nlm.nih.gov/pubmed/24102057
http://dx.doi.org/10.1155/2013/670139

Ejemplares similares